Morbidity and Mortality Weekly Report (MMWR)

This report describes characteristics of the XBB 1.5 Variant in New York City during November–December 2022.

This report describes surveillance of aircraft wastewater for early detection of potential COVID-19 variants.

This report describes postarrival COVID-19 testing among volunteering international air travelers.

This report describes 54% effectiveness for the 2023-23 influenza vaccine for preventing medically attended influenza A infection in people older than 65 years.

This report describes the percentage of women aged 50–74 years who had a mammogram within the past two years.

This report describes COVID-19 bivalent booster vaccination coverage and intent to receive booster vaccination among adolescents and adults.

This report describes low COVID-19 vaccination coverage with one or more dose among younger children compared to older children.

This report describes infrequent intake of fruits and vegetables among young children in the United States.

This report describes up to 4 months of protection against COVID-19 among children aged 3–5 and 3–4 year who received monovalent primary series vaccinations.

This report describes high typhoid incidence in South-East Asian, Easter Mediterranean, and African regions.

This report describes the percentage of adult aged ≥45 years who use a hearing aid.

This report describes an increase in suicide rates during 2021 in the United States.

This report describes higher protection against COVID-19 infection and death among people who received an updated booster than people who received a monovalent booster.

This report describes vaccine-specific changes in the 2023 immunization schedule for adults aged ≥19 years.

This report describes changes to the 2023 immunization schedule for children and adolescents aged ≤18 years.

This report describes how race, ethnicity, and socioeconomic factors affected hemodialysis-associated S. aureus bloodstream infections.

This report describes how the median completed COVID-19 vaccinations series among older adults in 2022 was 76%, which is below the WHO goal, especially in middle- and low-income countries.

This report describes how one third of people of all ages used telemedicine with in the previous 12 months during 2021.

This report describes measures that people who are immunocompromised can take to prevent and treat COVID-19.

This report describes how continued monitoring of S-gene target failure and S-gene target presence patterns will likely serve as a useful complement to genomic surveillance of SARS-CoV-2 lineages.

This report describes how a bivalent mRNA booster dose provided additional protection against symptomatic XBB/XBB.1.5 infection for at least the first 3 months after vaccination in persons who had previously received 2–4 monovalent vaccine doses.

This report describes 2021 data of the percentage of adults with arthritis by sex, race, and Hispanic origin in the United States.

Erratum for MMWR Vo. 70, RR-4

This report describes a broadened antibody response among nursing home residents who received an updated COVID-19 vaccine.

This report describes survey data showing a low proportion of U.S. adults met leisure-time physical activity guidelines.

This report describes lower weekly rates of COVID-19 among nursing home residents who are up to date with COVID-19 vaccination.

This report describes an increase in people with HIV infection receiving PEPFAR-supported antiretroviral therapy in Uganda.

This report describes a decline in the birth rate for females from 1991–2021 by age group.

Erratum for MMWR Vo. 71, No. 45

This report describes higher rates of pediatric hospitalization and symptomatic illness from influenza among children during the 2022–23 season in Tennessee.

This report describes an investigation of mental and physical health symptoms reported among residents a year after a chemical exposure fire in Winnebago County, Illinois.

This report describes an online survey of previously vaccinated residents and their reasons for not getting a bivalent COVID-19 booster dose.

This report describes epidemiology of mpox cases in six African counties and additional cases associated with travel that followed during 2018–2021.

This report describes inconsistencies and disparities in alcohol screening and brief intervention among pregnant persons in 2017 and 2019.

This report describes the prevalence of substance use among person with syphilis during pregnancy.

This report describes similar early safety findings from the Vaccine Adverse Event Reporting System for bivalent booster vaccination in children aged 5–11 years as the monovalent booster vaccination.

This report describes 2021 data from National Center for Health Interview Survey on the percentage of adults who have ever had hepatitis by age group and sex.

This report describes declines in vaccination coverage reported by the National Immunization Survey–Child among young children born during 2018–2019 living below the federal poverty level and in rural areas.

This report describes a cholera outbreak of more than 20,000 cases in Port-au-Prince.

This report describes a decrease in vaccination coverage among children in kindergarten in the United States during the 2021–22 school year.

This report describes the percentage of U.S. mothers with gestational diabetes by maternal age.

Erratum for MMWR Vo. 71, No. 46

This report describes overall low COVID-19 vaccination coverage among children and adolescents 5–17 years old and parental intent to vaccinate their child.

This report describes cases of mpox among cisgender women and the use of tecovirimat with no reported adverse reaction to treat four pregnant people with mpox.

This report describes and overall decrease in all age groups for patients who were prescribed opioids during ED visits for pain.

This report describes an analysis of mpox case data collected in New York City during the initial phase of the 2022 monkeypox outbreak.

This report describes fewer symptoms and lower rates of hospitalization from mpox among people who had received 1 dose of JYNNEOS vaccine.

This report describes disparities in the ongoing mpox outbreak among transgender and gender-diverse adults.

This report describes the effectiveness of the updated (bivalent) COVID-19 vaccines for prevention of COVID-19-associated hospitalization among adults ages 65 years or older who did not have a weakened immune system and who were hospitalized with COVID-19-like illness.

This report describes the effectiveness of the updated (bivalent) COVID-19 vaccines for prevention of COVID-19 associated emergency department and urgent care visits and hospitalization among adults ages 18 years or older without a weakened immune system.